MENU
CCXI
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

CCXI stock forecast, quote, news & analysis

Churchill Capital Corp XI is a blank check company... Show more

Industry: #Biotechnology
CCXI
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
Interact to see
Advertisement
A.I.Advisor
a Summary for CCXI with price predictions
Jul 10, 2026

Momentum Indicator for CCXI turns positive, indicating new upward trend

CCXI saw its Momentum Indicator move above the 0 level on June 05, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 24 similar instances where the indicator turned positive. In of the 24 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

CCXI moved above its 50-day moving average on June 15, 2026 date and that indicates a change from a downward trend to an upward trend.

The Aroon Indicator entered an Uptrend today. In of 104 cases where CCXI Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for CCXI moved out of overbought territory on July 07, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 5 similar instances where the indicator moved out of overbought territory. In of the 5 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 19 cases where CCXI's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

CCXI broke above its upper Bollinger Band on June 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CCXI’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CCXI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 99, placing this stock better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: CCXI's P/B Ratio (0.000) is slightly lower than the industry average of (1.763). P/E Ratio (0.000) is within average values for comparable stocks, (102.679). CCXI's Dividend Yield (0.000) is considerably lower than the industry average of (0.034). P/S Ratio (0.000) is also within normal values, averaging (1.790).

A.I.Advisor
published Highlights

Industry description

Financial conglomerates usually encompass a wide range of financial services including (not necessarily limited to) investment banking, insurance, capital raising/underwriting, trading of financial securities, investment advisory services, wealth management of high net-worth individuals, and retail banking. Think Citigroup, American Express Company, ING Group.

Market Cap

The average market capitalization across the Financial Conglomerates Industry is 267.18M. The market cap for tickers in the group ranges from 1 to 590.24B. IMAQU holds the highest valuation in this group at 590.24B. The lowest valued company is MDCE at 1.

High and low price notable news

The average weekly price growth across all stocks in the Financial Conglomerates Industry was -0%. For the same Industry, the average monthly price growth was -0%, and the average quarterly price growth was 1%. BKHA experienced the highest price growth at 14%, while AFJK experienced the biggest fall at -52%.

Volume

The average weekly volume growth across all stocks in the Financial Conglomerates Industry was -43%. For the same stocks of the Industry, the average monthly volume growth was -62% and the average quarterly volume growth was -71%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 36
P/E Growth Rating: 88
Price Growth Rating: 56
SMR Rating: 97
Profit Risk Rating: 99
Seasonality Score: 3 (-100 ... +100)
View a ticker or compare two or three
CCXI
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

a developer and commercializer of small molecule therapeutics

Industry FinancialConglomerates

Profile
Details
Industry
Biotechnology
Address
N/A
Phone
N/A
Employees
N/A
Web
N/A
Momentum Indicator for CCXI turns positive, indicating new upward trend